Skip to main content
Top
Published in: Journal of Nanoparticle Research 2/2015

01-02-2015 | Research Paper

pH-sensitive thiolated nanoparticles facilitate the oral delivery of insulin in vitro and in vivo

Authors: Yan Zhang, Xia Lin, Xuli Du, Sicong Geng, Hongren Li, Hong Sun, Xing Tang, Wei Xiao

Published in: Journal of Nanoparticle Research | Issue 2/2015

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

In this work, we designed and developed a delivery system composed of enteric Eudragit L100-cysteine/reduced glutathione nanoparticles (Eul-cys/GSH NPs) for oral delivery of insulin. First, interactions between Eul-cys and mucin glycoproteins, which are believed to be the result of disulfide bonds, were confirmed using rheology experiments. Subsequently, the insulin-loaded Eul-cys/GSH NPs were prepared by the diffusion method using the rich gel network multipore structure at the surface of the Eul-cys when the pH was higher than the pKa of Eul-cys polymer. The Eul-cys/GSH NPs obtained were characterized by dynamic light scattering, transmission electron microscopy, and atomic force microscopy. The results obtained showed that the average particle size ranged from 240 to 280 nm, and the particles were almost spherical in shape. The in vitro drug release results showed that the Eul-cys/GSH NPs retained a large amount of insulin in simulated gastric fluid, while a significant insulin release was found in simulated intestinal fluid. The in situ release study suggested that NPs released a greater amount of FITC-insulin (49.2 %) into the intestinal mucus layer compared with that of FITC-insulin solution (16.4 %), which facilitating insulin delivery through the intestinal mucosa. Eul-cys/GSH NPs exhibited promising mucoadhesive properties demonstrated using an in vitro cell model. Consequently, NPs were introduced into the ileum loop of healthy rats, thus enhancing the intestinal absorption of insulin and providing a prolonged reduction in blood glucose levels. These results suggest that Eul-cys/GSH NPs may be a promising delivery system for the treatment of diabetes.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literature
go back to reference Attivi D, Werhle P, Maincent P et al (2005) Formulation of insulin-loaded polymeric nanoparticles using response surface methodology. Drug Dev Ind Pharm 31:179–189CrossRef Attivi D, Werhle P, Maincent P et al (2005) Formulation of insulin-loaded polymeric nanoparticles using response surface methodology. Drug Dev Ind Pharm 31:179–189CrossRef
go back to reference Bakhru SH, Furtado S, Morello AP et al (2013) Oral delivery of proteins by biodegradable nanoparticles. Adv Drug Deliv Rev 65:811–821CrossRef Bakhru SH, Furtado S, Morello AP et al (2013) Oral delivery of proteins by biodegradable nanoparticles. Adv Drug Deliv Rev 65:811–821CrossRef
go back to reference Bernkop-Schnurch A, Guggi D, Pinter Y (2004) Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J Control Release 94:177–186CrossRef Bernkop-Schnurch A, Guggi D, Pinter Y (2004) Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J Control Release 94:177–186CrossRef
go back to reference Chen MC, Sonaje K, Sung HW et al (2011) A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. Biomaterials 32:9826–9838CrossRef Chen MC, Sonaje K, Sung HW et al (2011) A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. Biomaterials 32:9826–9838CrossRef
go back to reference Clausen A, Kast C, Bernkop-Schnurch A (2002) The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm Res 19:602–608CrossRef Clausen A, Kast C, Bernkop-Schnurch A (2002) The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm Res 19:602–608CrossRef
go back to reference Deat-Laine E, Hoffart V, Beyssac E et al (2012) Development and in vitro characterization of insulin loaded whey protein and alginate microparticles. Inter J Pharm 439:136–144CrossRef Deat-Laine E, Hoffart V, Beyssac E et al (2012) Development and in vitro characterization of insulin loaded whey protein and alginate microparticles. Inter J Pharm 439:136–144CrossRef
go back to reference Desai M, Labhasetwar V, Levy R et al (1996) Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13:1838–1845CrossRef Desai M, Labhasetwar V, Levy R et al (1996) Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13:1838–1845CrossRef
go back to reference Ensign LM, Cone R, Hanes J (2012) Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Adv Drug Deliv Rev 64:557–570CrossRef Ensign LM, Cone R, Hanes J (2012) Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Adv Drug Deliv Rev 64:557–570CrossRef
go back to reference Felber AE, Dufresne MH, Leroux JC (2012) pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv Drug Deliv Rev 64:979–992CrossRef Felber AE, Dufresne MH, Leroux JC (2012) pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv Drug Deliv Rev 64:979–992CrossRef
go back to reference Gamboa JM, Leong KW et al (2013) In vitro and in vivo models for the study of oral delivery of nanoparticles. Adv Drug Deliv Rev 65:800–810CrossRef Gamboa JM, Leong KW et al (2013) In vitro and in vivo models for the study of oral delivery of nanoparticles. Adv Drug Deliv Rev 65:800–810CrossRef
go back to reference Ganguly K, Chaturvedi K, Aminabhavi TM et al (2014) Polysaccharide-based micro/nanohydrogels for delivering macromolecular therapeutics. J Control Release 193:162–173CrossRef Ganguly K, Chaturvedi K, Aminabhavi TM et al (2014) Polysaccharide-based micro/nanohydrogels for delivering macromolecular therapeutics. J Control Release 193:162–173CrossRef
go back to reference George M, Abraham TE (2006) Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan—a review. J Control Release 114:1–14CrossRef George M, Abraham TE (2006) Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan—a review. J Control Release 114:1–14CrossRef
go back to reference Jain S, Rathi VV, Godugu C et al (2012) Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Nanomedicine 7:1311–1337CrossRef Jain S, Rathi VV, Godugu C et al (2012) Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Nanomedicine 7:1311–1337CrossRef
go back to reference Kawashima Y, Yamamoto H, Kuno Y et al (2000) Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol 5:77–85CrossRef Kawashima Y, Yamamoto H, Kuno Y et al (2000) Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol 5:77–85CrossRef
go back to reference Lai SK, Wang YY, Hanes J (2009) Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 61:158–171CrossRef Lai SK, Wang YY, Hanes J (2009) Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 61:158–171CrossRef
go back to reference Li M, Lu W, Zhang Q et al (2007) Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats. Int J Pharm 329:182–191CrossRef Li M, Lu W, Zhang Q et al (2007) Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats. Int J Pharm 329:182–191CrossRef
go back to reference Lin YH, Chung CK, Sung HW et al (2005) Preparation of nanoparticles composed of chitosan/poly-γ-glutamic acid and evaluation of their permeability through Caco-2 cells. Biomacromolecules 6:1104–1112CrossRef Lin YH, Chung CK, Sung HW et al (2005) Preparation of nanoparticles composed of chitosan/poly-γ-glutamic acid and evaluation of their permeability through Caco-2 cells. Biomacromolecules 6:1104–1112CrossRef
go back to reference Liu Y, Kong M, Chen XG et al (2013) Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers. Colloids Surf B 103:345–353CrossRef Liu Y, Kong M, Chen XG et al (2013) Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers. Colloids Surf B 103:345–353CrossRef
go back to reference Lopes MA, Abrahim BA, Ribeiro AJ et al (2014) Intestinal absorption of insulin nanoparticles: Contribution of M cells. Nanomedicine 10:1139–1151CrossRef Lopes MA, Abrahim BA, Ribeiro AJ et al (2014) Intestinal absorption of insulin nanoparticles: Contribution of M cells. Nanomedicine 10:1139–1151CrossRef
go back to reference Makhlof A, Tozuka Y, Takeuchi H (2011) Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 42:445–451CrossRef Makhlof A, Tozuka Y, Takeuchi H (2011) Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 42:445–451CrossRef
go back to reference Morishita M, Goto T, Lowman AM et al (2004) Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. J Control Release 97:115–124CrossRef Morishita M, Goto T, Lowman AM et al (2004) Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. J Control Release 97:115–124CrossRef
go back to reference Mundargi RC, Rangaswamy V, Aminabhavi TM (2011) pH-Sensitive oral insulin delivery systems using Eudragit microspheres. Drug Dev Ind Pharm 37:977–985CrossRef Mundargi RC, Rangaswamy V, Aminabhavi TM (2011) pH-Sensitive oral insulin delivery systems using Eudragit microspheres. Drug Dev Ind Pharm 37:977–985CrossRef
go back to reference Nakamura K, Murray RJ, Lowman AM (2004) Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. J Control Release 95:589–599CrossRef Nakamura K, Murray RJ, Lowman AM (2004) Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. J Control Release 95:589–599CrossRef
go back to reference Su FY, Lin KJ, Sung HW et al (2012) Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Biomaterials 33:2801–2811CrossRef Su FY, Lin KJ, Sung HW et al (2012) Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Biomaterials 33:2801–2811CrossRef
go back to reference Takeuchi H, Yamamoto H, Kawashima Y (2001) Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev 47:39–54CrossRef Takeuchi H, Yamamoto H, Kawashima Y (2001) Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev 47:39–54CrossRef
go back to reference Woitiski CB, Sarmento B, Veiga F (2011) Facilitated nanoscale delivery of insulin across intestinal membrane models. Int J Pharm 412:123–131CrossRef Woitiski CB, Sarmento B, Veiga F (2011) Facilitated nanoscale delivery of insulin across intestinal membrane models. Int J Pharm 412:123–131CrossRef
go back to reference Xiong XY, Li QH, Gong YC et al (2013) Pluronic P85/poly(lactic acid) vesicles as novel carrier for oral insulin delivery. Colloids Surf B 111:282–288CrossRef Xiong XY, Li QH, Gong YC et al (2013) Pluronic P85/poly(lactic acid) vesicles as novel carrier for oral insulin delivery. Colloids Surf B 111:282–288CrossRef
go back to reference Yang Y, Wang SP, Chen MW et al (2014) Advances in self-assembled chitosan nanomaterials for drug delivery. Biotechnol Adv 32:1301–1316CrossRef Yang Y, Wang SP, Chen MW et al (2014) Advances in self-assembled chitosan nanomaterials for drug delivery. Biotechnol Adv 32:1301–1316CrossRef
go back to reference Zhang Y, Du X, Tang X et al (2014) Thiolated Eudragit based nanoparticles for oral insulin delivery: preparation, characterization, and evaluation using intestinal epithelial cells in vitro. Macromol Biosci 14:842–852 Zhang Y, Du X, Tang X et al (2014) Thiolated Eudragit based nanoparticles for oral insulin delivery: preparation, characterization, and evaluation using intestinal epithelial cells in vitro. Macromol Biosci 14:842–852
go back to reference Zhang Y, Wu X, Tang X et al (2012) Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Int J Pharm 436:341–350CrossRef Zhang Y, Wu X, Tang X et al (2012) Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Int J Pharm 436:341–350CrossRef
go back to reference Zhao X, Shan C, Li R et al (2013) Preparation, characterization, and evaluation in vivo of Ins-SiO2-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin. Int J Pharm 454:278–284CrossRef Zhao X, Shan C, Li R et al (2013) Preparation, characterization, and evaluation in vivo of Ins-SiO2-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin. Int J Pharm 454:278–284CrossRef
Metadata
Title
pH-sensitive thiolated nanoparticles facilitate the oral delivery of insulin in vitro and in vivo
Authors
Yan Zhang
Xia Lin
Xuli Du
Sicong Geng
Hongren Li
Hong Sun
Xing Tang
Wei Xiao
Publication date
01-02-2015
Publisher
Springer Netherlands
Published in
Journal of Nanoparticle Research / Issue 2/2015
Print ISSN: 1388-0764
Electronic ISSN: 1572-896X
DOI
https://doi.org/10.1007/s11051-014-2847-7

Other articles of this Issue 2/2015

Journal of Nanoparticle Research 2/2015 Go to the issue

Premium Partners